Human ether-a-go-go related gene (hERG) K+ channels: Function and dysfunction

Progress in Biophysics and Molecular Biology

Volumn 98, Issue 2-3, 2008, Pages 137-148

  Perrin, Mark J ^a,b   Subbiah, Rajesh N ^a,b,c   Vandenberg, Jamie I ^a,b   Hill, Adam P ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Arrhythmias; Electrophysiology; Long QT syndrome; Voltage gated K+ channel

Indexed keywords

ERG1 POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG;

CHANNEL GATING; CHEMISTRY; GENETICS; GENOTYPE; HUMAN; LONG QT SYNDROME; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; REVIEW;

ETHER-A-GO-GO POTASSIUM CHANNELS; GENOTYPE; HUMANS; ION CHANNEL GATING; LONG QT SYNDROME; MUTATION; PHENOTYPE;

EID: 61849180389     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2008.10.006     Document Type: Review

References (138)

1. Akhavan A., Atanasiu R., Noguchi T., Han W., Holder N., and Shrier A. Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization. J. Cell Sci. 118 (2005) 2803-2812
2. Alabi A.A., Bahamonde M.I., Jung H.J., Kim J.I., and Swartz K.J. Portability of paddle motif function and pharmacology in voltage sensors. Nature 450 (2007) 370-375
3. Anderson C.L., Delisle B.P., Anson B.D., Kilby J.A., Will M.L., Tester D.J., Gong Q., Zhou Z., Ackerman M.J., and January C.T. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113 (2006) 365-373
4. Antzelevitch C. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Heart Rhythm: Off. J. Heart Rhythm Soc. 2 (2005) S9-15
5. Antzelevitch C. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 9 Suppl. 4 (2007) iv4-iv15
6. Antzelevitch C., Pollevick G., Cordeiro J., Casis O., Sanguinetti M., Aizawa Y., Guerchicoff A., Pfeiffer R., Oliva A., Wollnik B., Gelber P., Bonaros E., Burashnikov E., Wu Y., Sargent J., Schickel S., Oberheiden R., Bhatia A., Hsu L.F., Haïssaguerre M., Schimpf R., Borggrefe M., and Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by st-segment elevation, short qt intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
7. Attwell D., and Lee J.A. A cellular basis for the primary long q-t syndromes. Lancet 1 (1988) 1136-1139
8. Baukrowitz T., and Yellen G. Modulation of K+ current by frequency and external [K+]: a tale of two inactivation mechanisms. Neuron 15 (1995) 951-960
9. Bellocq C., Van Ginneken A., Bezzina C., Alders M., Escande D., Mannens M., Baro I., and Wilde A. Mutation in the kcnq1 gene leading to the short qt-interval syndrome. Circulation 109 (2004) 2394-2397
10. Benton R.E., Honig P.K., Zamani K., Cantilena L.R., and Woosley R.L. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin. Pharmacol. Ther. 59 (1996) 383-388
11. Berecki G., Zegers J.G., Verkerk A.O., Bhuiyan Z.A., de Jonge B., Veldkamp M.W., Wilders R., and van Ginneken A.C. HERG channel (dys)function revealed by dynamic action potential clamp technique. Biophys. J. 88 (2005) 566-578
12. Boyd S.D. Everything you wanted to know about small RNA but were afraid to ask. Lab Invest. 88 (2008) 569-578
13. Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M., Menendez T., Brugada J., Pollevick G., Wolpert C., Burashnikov E., Matsuo K., Wu Y., Guerchicoff A., Bianchi F., Giustetto C., Schimpf R., Brugada P., and Antzelevitch C. Sudden death associated with short-qt syndrome linked to mutations in herg. Circulation 109 (2003) 30-35
14. Busjahn A., Knoblauch H., Faulhaber H.D., Boeckel T., Rosenthal M., Uhlmann R., Hoehe M., Schuster H., and Luft F.C. QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 99 (1999) 3161-3164
15. Cavero I., Mestre M., Guillon J.M., and Crumb W. Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias. Expert Opin. Pharmacother. 1 (2000) 947-973
16. Chen J., Zou A., Splawski I., Keating M.T., and Sanguinetti M.C. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J. Biol. Chem. 274 (1999) 10113-10118
17. Chevalier P., Bellocq C., Millat G., Piqueras E., Potet F., Schott J.-J., Bar{\'o I., Lemarec H., Barhanin J., Rousson R., and Rodriguez-Lafrasse C. Torsades de pointes complicating atrioventricular block: evidence for a genetic predisposition. Heart Rhythm: Off. J. Heart Rhythm Soc. 4 (2007) 170-174
18. Clarke C.E., Hill A.P., Zhao J., Kondo M., Subbiah R.N., Campbell T.J., and Vandenberg J.I. Effect of S5P {alpha}-helix charge mutants on inactivation of hERG K+ channels. J. Physiol. 573 (2006) 291-304
19. Cui J., Melman Y., Palma E., Fishman G.I., and McDonald T.V. Cyclic AMP regulates the HERG K(+) channel by dual pathways. Curr. Biol. 10 (2000) 671-674
20. Curran M., Splawski I., Timothy K., Vincent G., Green E., and Keating M. A molecular basis for cardiac arrhythmia: herg mutations cause long qt syndrome. Cell 80 (1995) 795-803
21. Delisle B.P., Anson B.D., Rajamani S., and January C.T. Biology of cardiac arrhythmias: ion channel protein trafficking. Cir. Res. 94 (2004) 1418-1428
22. Denney S.D., Lakkireddy D.R., and Khan I.A. Long QT syndrome and torsade de pointes in transient left ventricular apical ballooning syndrome. Int. J. Cardiol. 100 (2005) 499-501
23. Dennis A., Wang L., Wan X., and Ficker E. hERG channel trafficking: novel targets in drug-induced long QT syndrome. Biochem. Soc. Trans. 35 (2007) 1060-1063
24. Dessertenne F. La tachycardie ventriculaire à deux foyers opposès variables. Archives des maladies du coeur et des vaisseaux 59 (1966) 263-272
25. Donger C., Denjoy I., Berthet M., Neyroud N., Cruaud C., Bennaceur M., Chivoret G., Schwartz K., Coumel P., and Guicheney P. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 96 (1997) 2778-2781
26. Doyle D.A., Morais Cabral J., Pfuetzner R.A., Kuo A., Gulbis J.M., Cohen S.L., Chait B.T., and MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 280 (1998) 69-77
27. Farid R., Day T., Friesner R.A., and Pearlstein R.A. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorg. Med. Chem. 14 (2006) 3160-3173
28. Fauchier L., Babuty D., Poret P., Autret M.L., Cosnay P., and Fauchier J.P. Effect of verapamil on QT interval dynamicity. Am. J. Cardiol. 83 807-8 (1999) A10-A11
29. Ficker E., Dennis A.T., Obejero-Paz C.A., Castaldo P., Taglialatela M., and Brown A.M. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. J. Mol. Cell Cardiol. 32 (2000) 2327-2337
30. Ficker E., Dennis A.T., Wang L., and Brown A.M. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ. Res. 92 (2003) e87-e100
31. Ficker E., Jarolimek W., Kiehn J., Baumann A., and Brown A.M. Molecular determinants of dofetilide block of HERG K+ channels. Circ. Res. 82 (1998) 386-395
32. Furutani M., Trudeau M.C., Hagiwara N., Seki A., Gong Q., Zhou Z., Imamura S., Nagashima H., Kasanuki H., Takao A., Momma K., January C.T., Robertson G.A., and Matsuoka R. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 99 (1999) 2290-2294
33. Goldstein J.L., and Brown M.S. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc. Natl. Acad. Sci. U S A 70 (1973) 2804-2808
34. Gong Q., Keeney D.R., Robinson J.C., and Zhou Z. Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome. J. Mol. Cell. Cardiol. 37 (2004) 1225-1233
35. Gong Q., Zhang L., Vincent G.M., Horne B.D., and Zhou Z. Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome. Circulation 116 (2007) 17-24
36. Gussak I., Brugada P., Brugada J., Wright R., Kopecky S., Chaitman B., and Bjerregaard P. Idiopathic short qt interval: a new clinical syndrome?. Cardiology 94 (2000) 99-102
37. Guth B.D. Preclinical cardiovascular risk assessment in modern drug development. Toxicol. Sci. 97 (2007) 4-20
38. Halkin A., Roth A., Lurie I., Fish R., Belhassen B., and Viskin S. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome. J. Am. Coll. Cardiol. 38 (2001) 1168-1174
39. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391 (1981) 85-100
40. Hardman R., Stansfeld P.J., Dalibalta S., Sutcliffe M.J., and Mitcheson J.S. Activation gating of hERG potassium channels: S6 glycines are not required as gating hinges. J. Biol. Chem. 282 (2007) 31972-31981
41. Herzberg I., Trudeau M., and Robertson G. Transfer of rapid inactivation and sensitivity to the class iii antiarrhythmic drug e-4031 from herg to m-eag channels. J. Physiol. 511 (1998) 3-14
42. Hong Y., Rautaharju P.M., Hopkins P.N., Arnett D.K., Djouss'e L., Pankow J.S., Sholinsky P., Rao D.C., and Province M.A. Familial aggregation of QT-interval variability in a general population: results from the NHLBI family heart study. Clin. Genet. 59 (2001) 171-177
43. Isken O., and Maquat L.E. Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev. 21 (2007) 1833-1856
44. Itoh T., Kikuchi K., Odagawa Y., Takata S., Yano K., Okada S., Haneda N., Ogawa S., Nakano O., Kawahara Y., Kasai H., Nakayama T., Fukutomi T., Sakurada H., Shimizu A., Yazaki Y., Nagai R., Nakamura Y., and Tanaka T. Correlation of genetic etiology with response to beta-adrenergic blockade among symptomatic patients with familial long-QT syndrome. J. Hum. Genet. 46 (2001) 38-40
45. Jackman W., Friday K., Anderson J., Aliot E., Clark M., and Lazzara R. The long qt syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog. Cardiovasc. Dis. 31 (1988) 115-172
46. Jervell A., and Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the q-t interval and sudden death. Am. Heart J. 54 (1957) 59-68
47. Jiang C., Atkinson D., Towbin J., Splawski I., Lehmann M., Li H., Timothy K., Taggart R., Schwartz P., and Vincent G. Two long qt syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat. Genet. 8 (1994) 141-147
48. Jiang M., Zhang M., Maslennikov I.V., Liu J., Wu D.M., Korolkova Y.V., Arseniev A.S., Grishin E.V., and Tseng G.N. Dynamic conformational changes of extracellular S5-P linkers in the hERG channel. J. Physiol. 569 (2005) 75-89
49. Kagan A., Yu Z., Fishman G.I., and McDonald T.V. The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J. Biol. Chem. 275 (2000) 11241-11248
50. Keating M., Atkinson D., Dunn C., Timothy K., Vincent G., and Leppert M. Linkage of a cardiac arrhythmia, the long qt syndrome, and the harvey ras-1 gene. Science 252 (1991) 704-706
51. Kincaid M.M., and Cooper A.A. Misfolded proteins traffic from the endoplasmic reticulum (ER) due to ER export signals. Mol. Biol. Cell 18 (2007) 455-463
52. Krikler D., and Curry P. Torsade dse pointes, an atypical ventricular tachycardia. Heart Br. Card. Soc. 38 (1976) 117-120
53. Kupershmidt S., Yang T., Chanthaphaychith S., Wang Z., Towbin J.A., and Roden D.M. Defective human Ether-a-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus. J. Biol. Chem. 277 (2002) 27442-27448
54. Kuzmiak H.A., and Maquat L.E. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol. Med. 12 (2006) 306-316
55. Lacerda A.E., Kuryshev Y.A., Chen Y., Renganathan M., Eng H., Danthi S.J., Kramer J.W., Yang T., and Brown A.M. Alfuzosin delays cardiac repolarization by a novel mechanism. J. Pharmacol. Exp. Ther. 324 (2008) 427-433
56. Lees-Miller J.P., Duan Y., Teng G.Q., Thorstad K., and Duff H.J. Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant. Circ. Res. 86 (2000) 507-513
57. Levy R. Clinical studies of quinidin iv. The clinical toxicology of quinidin. J. Am. Med. Assoc. 79 (1922) 1108-1113
58. Li X., Xu J., and Li M. The human delta1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression. J. Biol. Chem. 272 (1997) 705-708
59. London B., Trudeau M.C., Newton K.P., Beyer A.K., Copeland N.G., Gilbert D.J., Jenkins N.A., Satler C.A., and Robertson G.A. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ. Res. 81 (1997) 870-878
60. Long S.B., Campbell E.B., and Mackinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309 (2005) 897-903
61. Long S.B., Campbell E.B., and Mackinnon R. Voltage sensor of Kv1.2: structural basis of electromechanical coupling. Science 309 (2005) 903-908
62. Long S.B., Tao X., Campbell E.B., and MacKinnon R. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 450 (2007) 376-382
63. Lu Y., Mahaut-Smith M.P., Varghese A., Huang C.L., Kemp P.R., and Vandenberg J.I. Effects of premature stimulation on HERG K(+) channels. J. Physiol. 537 (2001) 843-851
64. Lubinski A., Kornacewicz-Jach Z., Wnuk-Wojnar A.M., Adamus J., Kempa M., Kròlak T., Lewicka-Nowak E., Radomski M., and Swiatecka G. The terminal portion of the T wave: a new electrocardiographic marker of risk of ventricular arrhythmias. Pacing Clin. Electrophysiol.: PACE 23 (2000) 1957-1959
65. Maquat L.E., Kinniburgh A.J., Beach L.R., Honig G.R., Lazerson J., Ershler W.B., and Ross J. Processing of human beta-globin mRNA precursor to mRNA is defective in three patients with beta+-thalassemia. Proc. Natl. Acad. Sci. U S A 77 (1980) 4287-4291
66. Margeta-Mitrovic M., Jan Y.N., and Jan L.Y. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27 (2000) 97-106
67. Masetti M., Cavalli A., and Recanatini M. Modeling the hERG potassium channel in a phospholipid bilayer: molecular dynamics and drug docking studies. J. Comput. Chem 29 (2007) 795-808
68. Meissner F.L. Taubstummheit and Taubstummenbildung. Leipzig and Heidelberg. Winter (1856) 119-120
69. Mitcheson J.S., Chen J., Lin M., Culberson C., and Sanguinetti M.C. A structural basis for drug-induced long QT syndrome. Proc. Natl. Acad. Sci. USA 97 (2000) 12329-12333
70. Morais Cabral J.H., Lee A., Cohen S.L., Chait B.T., Li M., and Mackinnon R. Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell 95 (1998) 649-655
71. Moss A.J., and Schwartz P.J. 25th anniversary of the International Long-QT syndrome registry: an ongoing quest to uncover the secrets of long-QT syndrome. Circulation 111 (2005) 1199-1201
72. Motté G., Coumel P., Abitbol G., Dessertenne F., and Slama R. The long qt syndrome and syncope caused by spike torsades. Archives des maladies du coeur et des vaisseaux 63 (1970) 831-853
73. Myokai T., Ryu S., Shimizu H., and Oiki S. Topological mapping of the asymmetric drug binding to the human ether-à-go-go-related gene product (HERG) potassium channel by use of tandem dimers. Mol. Pharmacol 73 6 (2008) 1643-1651
74. Nakajima T., Furukawa T., Hirano Y., Tanaka T., Sakurada H., Takahashi T., Nagai R., Itoh T., Katayama Y., Nakamura Y., and Hiraoka M. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2. Cardiovasc. Res. 44 (1999) 283-293
75. Nakajima T., Furukawa T., Tanaka T., Katayama Y., Nagai R., Nakamura Y., and Hiraoka M. Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation. Circ. Res. 83 (1998) 415-422
76. Napolitano C., Schwartz P.J., Brown A.M., Ronchetti E., Bianchi L., Pinnavaia A., Acquaro G., and Priori S.G. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J. Cardiovasc. Electrophysiol. 11 (2000) 691-696
77. Neher E., and Sakmann B. Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature 260 (1976) 799-802
78. Newton-Cheh C., Larson M.G., Corey D.C., Benjamin E.J., Herbert A.G., Levy D., D'Agostino R.B., and O'donnell C.J. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: the Framingham heart study. Heart Rhythm: Off. J. Heart Rhythm Soc. 2 (2005) 277-284
79. Opthof T., Coronel R., Wilms-Schopman F.J.G., Plotnikov A.N., Shlapakova I.N., Danilo P., Rosen M.R., and Janse M.J. Dispersion of Repolarization in Canine Ventricle and the Electrocardiographic T wave: Tp-e Interval does not Reflect Transmural Dispersion. Heart Rhythm: Off. J. Heart Rhythm Soc. 4 (2007) 341-348
80. Pasquale G.D., Lusa A.M., Manini G.L., Dominici P., Andreoli A., Limoni P., and Pinelli G. Cardiac arrhythmias associated with subarachnoid hemorrhage. Prospective study with dynamic electrocardiography. Giornale italiano di cardiologia 14 (1984) 323-329
81. Pathak M.M., Yarov-Yarovoy V., Agarwal G., Roux B., Barth P., Kohout S., Tombola F., and Isacoff E.Y. Closing in on the resting state of the Shaker K(+) channel. Neuron 56 (2007) 124-140
82. Petrov D.B. QT interval lengthening after fasting complicated by a sudden attack of torsades de pointes. Texas Heart Institute journal/from the Texas Heart Institute of St Luke's Episcopal Hospital. Texas Child Hosp. 30 (2003) 86-87
83. Piper D.R., Varghese A., Sanguinetti M.C., and Tristani-Firouzi M. Gating currents associated with intramembrane charge displacement in HERG potassium channels. Proc. Natl. Acad. Sci. U S A 100 (2003) 10534-10539
84. Priori S.G., Napolitano C., and Schwartz P.J. Low penetrance in the long-QT syndrome: clinical impact. Circulation 99 (1999) 529-533
85. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., and Cappelletti D. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348 (2003) 1866-1874
86. Priori S., Pandit S., Rivolta I., Berenfeld O., Ronchetti E., Dhamoon A., Napolitano C., Anumonwo J., Di Barletta M.R., Gudapakkam S., Bosi G., Stramba-Badiale M., and Jalife J. A novel form of short qt syndrome (sqt3) is caused by a mutation in the kcnj2 gene. Cir. Res. 96 (2005) 800-807
87. Rajamani S., Anderson C.L., Anson B.D., and January C.T. Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block. Circulation 105 (2002) 2830-2835
88. Recanatini M., Cavalli A., and Masetti M. Modeling hERG and its interactions with drugs: recent advances in light of current potassium channel simulations. ChemMedChem 3 (2008) 523-535
89. Robertson G.A. LQT2: amplitude reduction and loss of selectivity in the tail that wags the HERG channel. Circ. Res. 86 (2000) 492-493
90. Roden D.M. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin. Electrophysiol.: PACE 21 (1998) 1029-1034
91. Roden D.M. Drug-induced Prolongation of the QT Interval. N. Engl. J. Med. 350 (2004) 1013-1022
92. Roden D.M., Lazzara R., Rosen M., Schwartz P.J., Towbin J., and Vincent G.M. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation 94 (1996) 1996-2012
93. Romano C., Gemme G., and Pongiglione R. Rare cardiac arrythmias of the pediatric age. Ii. Syncopal attacks due to paroxysmal ventricular fibrillation. (presentation of 1st case in italian pediatric literature). La Clinica pediatrica 45 (1963) 656-683
94. Saenen J.B., Paulussen A.D.C., Jongbloed R.J., Marcelis C.L., Gilissen R.A.H.J., Aerssens J., Snyders D.J., and Raes A.L. A single hERG mutation underlying a spectrum of acquired and congenital long QT syndrome phenotypes. J. Mol. Cell Cardiol. 43 (2007) 63-72
95. Sanguinetti M.C., Curran M.E., Spector P.S., and Keating M.T. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U S A 93 (1996) 2208-2212
96. Sasano T., Ueda K., Orikabe M., Hirano Y., Kawano S., Yasunami M., Isobe M., Kimura A., and Hiraoka M. Novel C-terminus frameshift mutation, 1122fs/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation. J. Mol. Cell Cardiol. 37 (2004) 1205-1211
97. Schonherr R., and Heinemann S.H. Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel. J. Physiol. 493 Pt 3 (1996) 635-642
98. Schoonmaker F.W., Osteen R.T., and Greenfield Jr. J.C. Thioridazine (Mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker. Ann. Intern. Med. 65 (1966) 1076-1078
99. Schwartz P. Idiopathic long qt syndrome: progress and questions. Am. Heart J. 109 (1985) 399-411
100. Schwartz P., and Malliani A. Electrical alternation of the t-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long q-t syndrome. Am. Heart J. 89 (1975) 45-50
101. Schwartz P., Periti M., and Malliani A. The long q-t syndrome. Am. Heart J. 89 (1975) 378-390
102. Schwartz P.J., Priori S.G., and Napolitano C. How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome. J. Cardiovasc. Electrophysiol. 14 (2003) 1120-1121
103. Schwartz P.J., and Priori S.G. In: Zipes D., and Jalife J. (Eds). Long QT Syndrome Phenotype-Genotype Considerations. fourth ed. Cardiac Electrophysiology: from Cell to Bedside (2004), WB Saunders Co., Philadelphia, PN 651-659
104. Schwartz S., and Hallinger L. Transient ventricular fibrillation. Vi. Observations on the peripheral arterial pulse pressures in the course of transient ventricular fibrillation during established auriculoventricular dissociation. Am. Heart J. 48 (1954) 390-404
105. Schwartz P.J., Moss A.J., Vincent G.M., and Crampton R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation 88 2 (1993) 782-784
106. Selzer A., and Wray H. Quinidine syncope - paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation 30 (1964) 17-&
107. Sesti F., Abbott G.W., Wei J., Murray K.T., Saksena S., Schwartz P.J., Priori S.G., Roden D.M., George A.L., and Goldstein S.A. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc. Natl. Acad. Sci. U S A 97 (2000) 10613-10618
108. Shen N.V., and Pfaffinger P.J. Molecular recognition and assembly sequences involved in the subfamily-specific assembly of voltage-gated K+ channel subunit proteins. Neuron 14 (1995) 625-633
109. Shimizu M., Ino H., Okeie K., Yamaguchi M., Nagata M., Hayashi K., Itoh H., Iwaki T., Oe K., Konno T., and Mabuchi H. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin. Cardiol. 25 (2002) 335-339
110. Shyu A.B., Wilkinson M.F., and van Hoof A. Messenger RNA regulation: to translate or to degrade. Embo. J. 27 (2008) 471-481
111. Smith P.L., and Yellen G. Fast and slow voltage sensor movements in HERG potassium channels. J. Gen. Physiol. 119 (2002) 275-293
112. Smith P.L., Baukrowitz T., and Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379 (1996) 833-836
113. Spector P.S., Curran M.E., Zou A., Keating M.T., and Sanguinetti M.C. Fast inactivation causes rectification of the IKr channel. J. Gen. Physiol. 107 (1996) 611-619
114. Splawski I., Timothy K.W., Tateyama M., Clancy C.E., Malhotra A., Beggs A.H., Cappuccio F.P., Sagnella G.A., Kass R.S., and Keating M.T. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297 (2002) 1333-1336
115. Subbiah R.N., Kondo M., Campbell T.J., and Vandenberg J.I. Tryptophan scanning mutagenesis of the HERG K+ channel: the S4 domain is loosely packed and likely to be lipid exposed. J. Physiol. 569 (2005) 367-379
116. Taylor B.L., and Zhulin I.B. PAS domains: internal sensors of oxygen, redox potential, and light. Microbiol. Mol. Biol. Rev. 63 (1999) 479-506
117. Thavendiranathan P., Bagai A., Brokkhart M.A., and Choudhry N.K. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomised controlled trials. Arch. Intern. Med. 166 (2006) 2307-2313
118. Torres A.M., Bansal P.S., Sunde M., Clarke C.E., Bursill J.A., Smith D.J., Bauskin A., Breit S.N., Campbell T.J., Alewood P.F., Kuchel P.W., and Vandenberg J.I. Structure of the HERG K+ channel S5P extracellular linker: role of an amphipathic alpha-helix in C-type inactivation. J. Biol. Chem. 278 (2003) 42136-42148
119. Trudeau M.C., Warmke J.W., Ganetzky B., and Robertson G.A. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269 (2005) 92-95
120. Vandenberg J.I., Varghese A., Lu Y., Bursill J.A., Mahaut-Smith M.P., and Huang C.L.H. Temperature dependence of human ether-a-go-go-related gene currents. Am. J. Physiol. Cell Physiol. 291 (2006) C165-C175
121. Vincent G.M. Risk assessment in long QT syndrome: the Achilles heel of appropriate treatment. Heart Rhythm 2 (2005) 505-506
122. Walker V.E., Atanasiu R., Lam H., and Shrier A. Co-chaperone FKBP38 promotes HERG trafficking. J. Biol. Chem. 282 (2007) 23509-23516
123. Wang Q., Curran M., Splawski I., Burn T., Millholland J., Vanraay T., Shen J., Timothy K., Vincent G., De Jager T., Schwartz P., Toubin J., Moss A., Atkinson D., Landes G., Connors T., and Keating M. Positional cloning of a novel potassium channel gene: Kvlqt1 mutations cause cardiac arrhythmias. Nat. Genet. 12 (1996) 17-23
124. Wang Q., Shen J., Li Z., Timothy K., Vincent G., Priori S., Schwartz P., and Keating M. Cardiac sodium channel mutations in patients with long qt syndrome, an inherited cardiac arrhythmia. Human Mol. Genet. 4 (1995) 1603-1607
125. Ward O. A new familial cardiac syndrome in children. J. Ir. Med. Assoc. 54 (1964) 103-106
126. Xia Y., Liang Y., Kongstad O., Liao Q., Holm M., Olsson B., and Yuan S. In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine. Heart Rhythm: Off. J. Heart Rhythm Soc. 2 (2005) 162-169
127. Xiao J., Luo X., Lin H., Zhang Y., Lu Y., Wang N., Zhang Y., Yang B., and Wang Z. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem. 282 (2007) 12363-12367
128. Yamaguchi M., Shimizu M., Ino H., Terai H., Uchiyama K., Oe K., Mabuchi T., Konno T., Kaneda T., and Mabuchi H. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin. Sci. 105 (2003) 671-676
129. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C., Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T., Norris K., George A.L., and Roden D.M. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 (2002) 1943-1948
130. Yang T., Snyders D., and Roden D.M. Drug block of I(kr): model systems and relevance to human arrhythmias. J. Cardiovasc. Pharmacol. 38 (2001) 737-744
131. Yanowitz F., Preston J., and Abildskov J. Functional distribution of right and left stellate innervation to the ventricles. Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Cir. Res. 18 (1966) 416-428
132. Yellen G. The voltage-gated potassium channels and their relatives. Nature 419 (2002) 35-42
133. Zareba W., Moss A.J., Schwartz P.J., Vincent G.M., Robinson J.L., Priori S.G., Benhorin J., Locati E.H., Towbin J.A., Keating M.T., Lehmann M.H., and Hall W.J. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N. Engl. J. Med. 339 (1998) 960-965
134. Zerangue N., Schwappach B., Jan Y.N., and Jan L.Y. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22 (1999) 537-548
135. Zhang M., Liu J., and Tseng G.N. Gating charges in the activation and inactivation processes of the HERG channel. J. Gen. Physiol. 124 (2004) 703-718
136. Zhou Z., Gong Q., Ye B., Fan Z., Makielski J.C., Robertson G.A., and January C.T. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys. J. 74 (1998) 230-241
137. Zipes D.P. The long QT interval syndrome. A Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 84 (1991) 1414-1419
138. Zwillinger L. Über die magnesiumwirkung auf das herz. J. Mol. Med. 14 (1935) 1429-1433